Urgent.News

What's breaking now, across thousands of outlets.

Business

Cipla partners with Qilu to license, supply Keytruda biosimilar in US

Cipla's US subsidiary Invagen Pharmaceuticals will market Qilu Pharmaceutical's QL2107, a biosimilar to Merck's cancer drug Keytruda, in the United States

Cipla partners with Qilu to license, supply Keytruda biosimilar in US

We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.

Read the original at business-standard.com →

More in Business

NOCs mandatory for kite manufacturers ahead of Basant

LAHORE: In a step toward safely reviving the provincial capital’s iconic traditional festival, the Lahore district administration has mandated formal registration and No Objection Certificates (NOCs) for all kite and thread manufacturers ahead of Safe Basant 2027.

PM directs to make Daanish University a model

ISLAMABAD: Prime Minister Shehbaz Sharif on Thursday directed that the proposed Daanish University be developed on a model distinct from conventional universities, with a focus on providing quality education to talented students from disadvantaged backgrounds.

More from Friday 4 September →